UK markets open in 6 hours 45 minutes

Novo Nordisk A/S (NVO)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
131.89-1.15 (-0.86%)
At close: 04:00PM EDT
131.75 -0.14 (-0.11%)
After hours: 07:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 586.14B
Enterprise value 588.71B
Trailing P/E 45.39
Forward P/E 39.06
PEG ratio (5-yr expected) 2.33
Price/sales (ttm)16.59
Price/book (mrq)40.70
Enterprise value/revenue 16.55
Enterprise value/EBITDA 32.61

Trading information

Stock price history

Beta (5Y monthly) 0.19
52-week change 354.69%
S&P500 52-week change 326.49%
52-week high 3138.28
52-week low 375.56
50-day moving average 3128.16
200-day moving average 3108.64

Share statistics

Avg vol (3-month) 34.58M
Avg vol (10-day) 33.56M
Shares outstanding 54.45B
Implied shares outstanding 64.46B
Float 83.19B
% held by insiders 10.00%
% held by institutions 19.74%
Shares short (30 Apr 2024) 43.64M
Short ratio (30 Apr 2024) 41.01
Short % of float (30 Apr 2024) 4N/A
Short % of shares outstanding (30 Apr 2024) 40.08%
Shares short (prior month 28 Mar 2024) 42.83M

Dividends & splits

Forward annual dividend rate 41.37
Forward annual dividend yield 41.04%
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 41.60
Payout ratio 447.42%
Dividend date 302 Apr 2024
Ex-dividend date 422 Mar 2024
Last split factor 22:1
Last split date 320 Sept 2023

Financial highlights

Currency in DKK.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024


Profit margin 36.55%
Operating margin (ttm)48.73%

Management effectiveness

Return on assets (ttm)25.24%
Return on equity (ttm)99.87%

Income statement

Revenue (ttm)244.24B
Revenue per share (ttm)54.60
Quarterly revenue growth (yoy)22.50%
Gross profit (ttm)N/A
EBITDA 117.85B
Net income avi to common (ttm)89.28B
Diluted EPS (ttm)2.90
Quarterly earnings growth (yoy)28.20%

Balance sheet

Total cash (mrq)9.3B
Total cash per share (mrq)2.09
Total debt (mrq)26.93B
Total debt/equity (mrq)27.22%
Current ratio (mrq)0.70
Book value per share (mrq)22.18

Cash flow statement

Operating cash flow (ttm)93.41B
Levered free cash flow (ttm)40.24B